By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aragon Pharmaceuticals, Inc. (Acquired by Johnson & Johnson) 

12780 El Camino Real
Suite 301
San Diego  California  92130  U.S.A.
Phone: 858-369-7600 Fax: 858-369-7650


SEARCH JOBS



Segment
Pharmaceuticals





Company News
Johnson & Johnson (JNJ) Completes Acquisition of Aragon Pharmaceuticals, Inc. 8/20/2013 9:36:39 AM
Johnson & Johnson (JNJ) to Buy Aragon Pharmaceuticals, Inc. for Up to $1 Billion 6/17/2013 7:06:06 AM
Aragon Pharmaceuticals, Inc. Announces First Patient Dosed in Phase I Study of ARN-810 in Estrogen Receptor Positive Breast Cancer 4/4/2013 9:22:28 AM
Aragon Pharmaceuticals, Inc. Announces Key Strategic Hire 2/11/2013 9:25:19 AM
Aragon Pharmaceuticals, Inc. Wins Key Legal Ruling Against Medivation, Inc. (MDVN) 1/4/2013 7:20:44 AM
Aragon Pharmaceuticals, Inc. Snags $50 Million Series D 10/4/2012 6:18:41 AM
Aragon Pharmaceuticals, Inc. Announces Clinical Results from Ongoing Phase II Trial Confirming Robust Anti-Tumor Activity and Tolerability of ARN-509 in Three Different Patient Populations of Castration Resistant Prostate Cancer 10/1/2012 10:54:43 AM
Aragon Pharmaceuticals, Inc. Raises $50 Million 10/1/2012 7:24:06 AM
Aragon Pharmaceuticals, Inc. Announces Appointment of Faheem Hasnain as Independent Director 8/28/2012 10:49:42 AM
Aragon Pharmaceuticals, Inc. Nabs $42 Million, Targets Hormone-Driven Cancers 3/6/2012 6:33:37 AM
12
//-->